1. Home
  2. CVE Database
  3. CVE-2022-47376
HIGH · 7.3

CVE-2022-47376

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installatio...

Vulnerability Description

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

CVSS Score

7.3

HIGH

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
LOW

Affected Products

VendorProductVersions
BdAlaris Infusion Central>= 1.1, <= 1.3.2

Related Weaknesses (CWE)

CWE-522CWE-257

References

FAQ

What is CVE-2022-47376?

CVE-2022-47376 is a vulnerability with a CVSS score of 7.3 (HIGH). The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installatio...

How severe is CVE-2022-47376?

CVE-2022-47376 has been rated HIGH with a CVSS base score of 7.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-47376?

Check the references section above for vendor advisories and patch information. Affected products include: Bd Alaris Infusion Central.